APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lipid Nanoparticle Solutions

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Lipid Nanoparticle Solutions Industry Growth and Trends Forecast to 2032

15 April 2026114 pages

Choose your research edition.

Industry ResearchLipid Nanoparticle Solutions Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Lipid Nanoparticle Solutions Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Lipid Nanoparticle Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lipid Nanoparticle Solutions Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Lipid Nanoparticle Solutions Market Analysis and Forecast 2026-2032188 pages · $4,950 USD

Market perspective

According to APO Research, the global Lipid Nanoparticle Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lipid Nanoparticle Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lipid Nanoparticle Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lipid Nanoparticle Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Lipid Nanoparticle Solutions market include Merck, Cytiva, GenScript, Creative Biolabs, WuXi STA, Carcell, Croda International, Detai Biotechnology and Waters, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lipid Nanoparticle Solutions market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lipid Nanoparticle Solutions market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lipid Nanoparticle Solutions market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lipid Nanoparticle Solutions.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Lipid Nanoparticle Solutions market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lipid Nanoparticle Solutions Market by Company

Merck

Cytiva

GenScript

Creative Biolabs

WuXi STA

Carcell

Croda International

Detai Biotechnology

Waters

MicroNano Biologics

Precigenome

Evonik

Avanti Polar Lipids

Genevant Sciences

Exelead

Nippon Fine Chemical

Lipoid

Lipid Nanoparticle Solutions Segment by Type

Solid Lipid Nanoparticles

Nanostructured Lipid Carriers

Cationic Lipid-Nucleic Acid Complexes

Lipid Nanoparticle Solutions Segment by Application

Gene Therapy

Vaccine Development

Cancer Treatment

Lipid Nanoparticle Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Nanoparticle Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lipid Nanoparticle Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Nanoparticle Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Lipid Nanoparticle Solutions companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Lipid Nanoparticle Solutions Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Lipid Nanoparticle Solutions Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Lipid Nanoparticle Solutions Market Share by Region (2021-2026) Table 4. Global Lipid Nanoparticle Solutions Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Lipid Nanoparticle Solutions Market Share by Region (2027-2032) Table 6. Global Lipid Nanoparticle Solutions Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Lipid Nanoparticle Solutions Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Lipid Nanoparticle Solutions Market Size Share by Type (2021-2026) Table 9. Global Lipid Nanoparticle Solutions Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Lipid Nanoparticle Solutions Market Size Share Forecasted by Type (2027-2032) Table 11. North America Lipid Nanoparticle Solutions Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Lipid Nanoparticle Solutions Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Lipid Nanoparticle Solutions Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Lipid Nanoparticle Solutions Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Lipid Nanoparticle Solutions Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Lipid Nanoparticle Solutions Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Lipid Nanoparticle Solutions Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Lipid Nanoparticle Solutions Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Lipid Nanoparticle Solutions Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Lipid Nanoparticle Solutions Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Lipid Nanoparticle Solutions Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Lipid Nanoparticle Solutions Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Lipid Nanoparticle Solutions Market Size Share by Application (2021-2026) Table 24. Global Lipid Nanoparticle Solutions Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Lipid Nanoparticle Solutions Market Size Share Forecasted by Application (2027-2032) Table 26. North America Lipid Nanoparticle Solutions Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Lipid Nanoparticle Solutions Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Lipid Nanoparticle Solutions Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Lipid Nanoparticle Solutions Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Lipid Nanoparticle Solutions Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Lipid Nanoparticle Solutions Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Lipid Nanoparticle Solutions Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Lipid Nanoparticle Solutions Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Lipid Nanoparticle Solutions Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Lipid Nanoparticle Solutions Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Lipid Nanoparticle Solutions Industry Trends Table 37. Lipid Nanoparticle Solutions Industry Drivers Table 38. Lipid Nanoparticle Solutions Industry Opportunities and Challenges Table 39. Lipid Nanoparticle Solutions Industry Restraints Table 40. Global Lipid Nanoparticle Solutions Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Lipid Nanoparticle Solutions Revenue Market Share by Company (2021-2026) Table 42. Global Lipid Nanoparticle Solutions Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Lipid Nanoparticle Solutions Key Company Headquarters & Area Served Table 44. Global Lipid Nanoparticle Solutions Company, Product Type & Application Table 45. Global Lipid Nanoparticle Solutions Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Lipid Nanoparticle Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Merck Company Information Table 49. Merck Business Overview Table 50. Merck Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Merck Lipid Nanoparticle Solutions Product Portfolio Table 52. Merck Recent Development Table 53. Cytiva Company Information Table 54. Cytiva Business Overview Table 55. Cytiva Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Cytiva Lipid Nanoparticle Solutions Product Portfolio Table 57. Cytiva Recent Development Table 58. GenScript Company Information Table 59. GenScript Business Overview Table 60. GenScript Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. GenScript Lipid Nanoparticle Solutions Product Portfolio Table 62. GenScript Recent Development Table 63. Creative Biolabs Company Information Table 64. Creative Biolabs Business Overview Table 65. Creative Biolabs Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Creative Biolabs Lipid Nanoparticle Solutions Product Portfolio Table 67. Creative Biolabs Recent Development Table 68. WuXi STA Company Information Table 69. WuXi STA Business Overview Table 70. WuXi STA Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. WuXi STA Lipid Nanoparticle Solutions Product Portfolio Table 72. WuXi STA Recent Development Table 73. Carcell Company Information Table 74. Carcell Business Overview Table 75. Carcell Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Carcell Lipid Nanoparticle Solutions Product Portfolio Table 77. Carcell Recent Development Table 78. Croda International Company Information Table 79. Croda International Business Overview Table 80. Croda International Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Croda International Lipid Nanoparticle Solutions Product Portfolio Table 82. Croda International Recent Development Table 83. Detai Biotechnology Company Information Table 84. Detai Biotechnology Business Overview Table 85. Detai Biotechnology Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Detai Biotechnology Lipid Nanoparticle Solutions Product Portfolio Table 87. Detai Biotechnology Recent Development Table 88. Waters Company Information Table 89. Waters Business Overview Table 90. Waters Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Waters Lipid Nanoparticle Solutions Product Portfolio Table 92. Waters Recent Development Table 93. MicroNano Biologics Company Information Table 94. MicroNano Biologics Business Overview Table 95. MicroNano Biologics Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. MicroNano Biologics Lipid Nanoparticle Solutions Product Portfolio Table 97. MicroNano Biologics Recent Development Table 98. Precigenome Company Information Table 99. Precigenome Business Overview Table 100. Precigenome Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Precigenome Lipid Nanoparticle Solutions Product Portfolio Table 102. Precigenome Recent Development Table 103. Evonik Company Information Table 104. Evonik Business Overview Table 105. Evonik Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Evonik Lipid Nanoparticle Solutions Product Portfolio Table 107. Evonik Recent Development Table 108. Avanti Polar Lipids Company Information Table 109. Avanti Polar Lipids Business Overview Table 110. Avanti Polar Lipids Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Avanti Polar Lipids Lipid Nanoparticle Solutions Product Portfolio Table 112. Avanti Polar Lipids Recent Development Table 113. Genevant Sciences Company Information Table 114. Genevant Sciences Business Overview Table 115. Genevant Sciences Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Genevant Sciences Lipid Nanoparticle Solutions Product Portfolio Table 117. Genevant Sciences Recent Development Table 118. Exelead Company Information Table 119. Exelead Business Overview Table 120. Exelead Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Exelead Lipid Nanoparticle Solutions Product Portfolio Table 122. Exelead Recent Development Table 123. Nippon Fine Chemical Company Information Table 124. Nippon Fine Chemical Business Overview Table 125. Nippon Fine Chemical Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Nippon Fine Chemical Lipid Nanoparticle Solutions Product Portfolio Table 127. Nippon Fine Chemical Recent Development Table 128. Lipoid Company Information Table 129. Lipoid Business Overview Table 130. Lipoid Lipid Nanoparticle Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Lipoid Lipid Nanoparticle Solutions Product Portfolio Table 132. Lipoid Recent Development Table 133. North America Lipid Nanoparticle Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Lipid Nanoparticle Solutions Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Lipid Nanoparticle Solutions Market Share by Country (2021-2026) Table 136. North America Lipid Nanoparticle Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Lipid Nanoparticle Solutions Market Share Forecast by Country (2027-2032) Table 138. Europe Lipid Nanoparticle Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Lipid Nanoparticle Solutions Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Lipid Nanoparticle Solutions Market Share by Country (2021-2026) Table 141. Europe Lipid Nanoparticle Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Lipid Nanoparticle Solutions Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Lipid Nanoparticle Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Lipid Nanoparticle Solutions Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Lipid Nanoparticle Solutions Market Share by Country (2021-2026) Table 146. Asia-Pacific Lipid Nanoparticle Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Lipid Nanoparticle Solutions Market Share Forecast by Country (2027-2032) Table 148. Latin America Lipid Nanoparticle Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Lipid Nanoparticle Solutions Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Lipid Nanoparticle Solutions Market Share by Country (2021-2026) Table 151. Latin America Lipid Nanoparticle Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Lipid Nanoparticle Solutions Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Lipid Nanoparticle Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Lipid Nanoparticle Solutions Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Lipid Nanoparticle Solutions Market Share by Country (2021-2026) Table 156. Middle East & Africa Lipid Nanoparticle Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Lipid Nanoparticle Solutions Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Lipid Nanoparticle Solutions Product Image Figure 3. Global Lipid Nanoparticle Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Lipid Nanoparticle Solutions Market Size (2021-2032) & (US$ Million) Figure 5. Global Lipid Nanoparticle Solutions Market Share by Region: 2025 VS 2032 Figure 6. Global Lipid Nanoparticle Solutions Market Share by Region (2021-2032) Figure 7. North America Lipid Nanoparticle Solutions Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Lipid Nanoparticle Solutions Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Lipid Nanoparticle Solutions Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Lipid Nanoparticle Solutions Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Lipid Nanoparticle Solutions Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Solid Lipid Nanoparticles Image Figure 13. Global Solid Lipid Nanoparticles Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Nanostructured Lipid Carriers Image Figure 15. Global Nanostructured Lipid Carriers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Cationic Lipid-Nucleic Acid Complexes Image Figure 17. Global Cationic Lipid-Nucleic Acid Complexes Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Lipid Nanoparticle Solutions Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Lipid Nanoparticle Solutions Market Share by Type 2025 VS 2032 Figure 20. North America Lipid Nanoparticle Solutions Market Size Share by Type (2021-2032) Figure 21. Europe Lipid Nanoparticle Solutions Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Lipid Nanoparticle Solutions Market Size Share by Type (2021-2032) Figure 23. Latin America Lipid Nanoparticle Solutions Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Lipid Nanoparticle Solutions Market Size Share by Type (2021-2032) Figure 25. Gene Therapy Image Figure 26. Global Gene Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Vaccine Development Image Figure 28. Global Vaccine Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Cancer Treatment Image Figure 30. Global Cancer Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Lipid Nanoparticle Solutions Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Lipid Nanoparticle Solutions Market Share by Application 2025 VS 2032 Figure 33. North America Lipid Nanoparticle Solutions Market Size Share by Application (2021-2032) Figure 34. Europe Lipid Nanoparticle Solutions Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Lipid Nanoparticle Solutions Market Size Share by Application (2021-2032) Figure 36. Latin America Lipid Nanoparticle Solutions Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Lipid Nanoparticle Solutions Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Lipid Nanoparticle Solutions Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Lipid Nanoparticle Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Lipid Nanoparticle Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Lipid Nanoparticle Solutions Market Share by Country (2021-2032) Figure 43. Europe Lipid Nanoparticle Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Lipid Nanoparticle Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Lipid Nanoparticle Solutions Market Share by Country (2021-2032) Figure 46. Asia-Pacific Lipid Nanoparticle Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Lipid Nanoparticle Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Lipid Nanoparticle Solutions Market Share by Country (2021-2032) Figure 49. Latin America Lipid Nanoparticle Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Lipid Nanoparticle Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Lipid Nanoparticle Solutions Market Share by Country (2021-2032) Figure 52. Middle East & Africa Lipid Nanoparticle Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Lipid Nanoparticle Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Lipid Nanoparticle Solutions Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Solid Lipid Nanoparticles
  • Nanostructured Lipid Carriers
  • Cationic Lipid-Nucleic Acid Complexes
Applications
  • Gene Therapy
  • Vaccine Development
  • Cancer Treatment
Companies covered
  • Merck
  • Cytiva
  • GenScript
  • Creative Biolabs
  • WuXi STA
  • Carcell
  • Croda International
  • Detai Biotechnology
  • Waters
  • MicroNano Biologics
  • Precigenome
  • Evonik
  • Avanti Polar Lipids
  • Genevant Sciences
  • Exelead
  • Nippon Fine Chemical
  • Lipoid

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Lipid Nanoparticle Solutions Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Lipid Nanoparticle Solutions Market Size by Region (2021-2032)
  5. 1.4.1 Global Lipid Nanoparticle Solutions Market Size by Region (2021-2026)
  6. 1.4.2 Global Lipid Nanoparticle Solutions Market Size by Region (2027-2032)
  7. 1.5 Key Regions Lipid Nanoparticle Solutions Market Size (2021-2032)
  8. 1.5.1 North America Lipid Nanoparticle Solutions Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Lipid Nanoparticle Solutions Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Lipid Nanoparticle Solutions Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Lipid Nanoparticle Solutions Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Lipid Nanoparticle Solutions Market Size Growth Rate (2021-2032)
2 Lipid Nanoparticle Solutions Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Solid Lipid Nanoparticles
  3. 2.1.2 Nanostructured Lipid Carriers
  4. 2.1.3 Cationic Lipid-Nucleic Acid Complexes
  5. 2.2 Global Lipid Nanoparticle Solutions Market Size by Type
  6. 2.2.1 Global Lipid Nanoparticle Solutions Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Lipid Nanoparticle Solutions Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Lipid Nanoparticle Solutions Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Lipid Nanoparticle Solutions Market Size by Regions
  10. 2.3.1 North America Lipid Nanoparticle Solutions Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Lipid Nanoparticle Solutions Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Lipid Nanoparticle Solutions Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Lipid Nanoparticle Solutions Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Lipid Nanoparticle Solutions Market Size Breakdown by Type (2021-2026)
3 Lipid Nanoparticle Solutions Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Gene Therapy
  3. 3.1.2 Vaccine Development
  4. 3.1.3 Cancer Treatment
  5. 3.2 Global Lipid Nanoparticle Solutions Market Size by Application
  6. 3.2.1 Global Lipid Nanoparticle Solutions Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Lipid Nanoparticle Solutions Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Lipid Nanoparticle Solutions Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Lipid Nanoparticle Solutions Market Size by Regions
  10. 3.3.1 North America Lipid Nanoparticle Solutions Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Lipid Nanoparticle Solutions Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Lipid Nanoparticle Solutions Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Lipid Nanoparticle Solutions Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Lipid Nanoparticle Solutions Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Lipid Nanoparticle Solutions Industry Trends
  2. 4.2 Lipid Nanoparticle Solutions Industry Drivers
  3. 4.3 Lipid Nanoparticle Solutions Industry Opportunities and Challenges
  4. 4.4 Lipid Nanoparticle Solutions Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Lipid Nanoparticle Solutions Revenue (2021-2026)
  2. 5.2 Global Lipid Nanoparticle Solutions Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Lipid Nanoparticle Solutions Key Company Headquarters & Area Served
  4. 5.4 Global Lipid Nanoparticle Solutions Company, Product Type & Application
  5. 5.5 Global Lipid Nanoparticle Solutions Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Lipid Nanoparticle Solutions Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Lipid Nanoparticle Solutions Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Lipid Nanoparticle Solutions Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Merck Lipid Nanoparticle Solutions Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Cytiva
  8. 6.2.1 Cytiva Company Information
  9. 6.2.2 Cytiva Business Overview
  10. 6.2.3 Cytiva Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Cytiva Lipid Nanoparticle Solutions Product Portfolio
  12. 6.2.5 Cytiva Recent Developments
  13. 6.3 GenScript
  14. 6.3.1 GenScript Company Information
  15. 6.3.2 GenScript Business Overview
  16. 6.3.3 GenScript Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 GenScript Lipid Nanoparticle Solutions Product Portfolio
  18. 6.3.5 GenScript Recent Developments
  19. 6.4 Creative Biolabs
  20. 6.4.1 Creative Biolabs Company Information
  21. 6.4.2 Creative Biolabs Business Overview
  22. 6.4.3 Creative Biolabs Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Creative Biolabs Lipid Nanoparticle Solutions Product Portfolio
  24. 6.4.5 Creative Biolabs Recent Developments
  25. 6.5 WuXi STA
  26. 6.5.1 WuXi STA Company Information
  27. 6.5.2 WuXi STA Business Overview
  28. 6.5.3 WuXi STA Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 WuXi STA Lipid Nanoparticle Solutions Product Portfolio
  30. 6.5.5 WuXi STA Recent Developments
  31. 6.6 Carcell
  32. 6.6.1 Carcell Company Information
  33. 6.6.2 Carcell Business Overview
  34. 6.6.3 Carcell Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Carcell Lipid Nanoparticle Solutions Product Portfolio
  36. 6.6.5 Carcell Recent Developments
  37. 6.7 Croda International
  38. 6.7.1 Croda International Company Information
  39. 6.7.2 Croda International Business Overview
  40. 6.7.3 Croda International Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Croda International Lipid Nanoparticle Solutions Product Portfolio
  42. 6.7.5 Croda International Recent Developments
  43. 6.8 Detai Biotechnology
  44. 6.8.1 Detai Biotechnology Company Information
  45. 6.8.2 Detai Biotechnology Business Overview
  46. 6.8.3 Detai Biotechnology Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Detai Biotechnology Lipid Nanoparticle Solutions Product Portfolio
  48. 6.8.5 Detai Biotechnology Recent Developments
  49. 6.9 Waters
  50. 6.9.1 Waters Company Information
  51. 6.9.2 Waters Business Overview
  52. 6.9.3 Waters Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Waters Lipid Nanoparticle Solutions Product Portfolio
  54. 6.9.5 Waters Recent Developments
  55. 6.10 MicroNano Biologics
  56. 6.10.1 MicroNano Biologics Company Information
  57. 6.10.2 MicroNano Biologics Business Overview
  58. 6.10.3 MicroNano Biologics Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 MicroNano Biologics Lipid Nanoparticle Solutions Product Portfolio
  60. 6.10.5 MicroNano Biologics Recent Developments
  61. 6.11 Precigenome
  62. 6.11.1 Precigenome Company Information
  63. 6.11.2 Precigenome Business Overview
  64. 6.11.3 Precigenome Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Precigenome Lipid Nanoparticle Solutions Product Portfolio
  66. 6.11.5 Precigenome Recent Developments
  67. 6.12 Evonik
  68. 6.12.1 Evonik Company Information
  69. 6.12.2 Evonik Business Overview
  70. 6.12.3 Evonik Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Evonik Lipid Nanoparticle Solutions Product Portfolio
  72. 6.12.5 Evonik Recent Developments
  73. 6.13 Avanti Polar Lipids
  74. 6.13.1 Avanti Polar Lipids Company Information
  75. 6.13.2 Avanti Polar Lipids Business Overview
  76. 6.13.3 Avanti Polar Lipids Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Avanti Polar Lipids Lipid Nanoparticle Solutions Product Portfolio
  78. 6.13.5 Avanti Polar Lipids Recent Developments
  79. 6.14 Genevant Sciences
  80. 6.14.1 Genevant Sciences Company Information
  81. 6.14.2 Genevant Sciences Business Overview
  82. 6.14.3 Genevant Sciences Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Genevant Sciences Lipid Nanoparticle Solutions Product Portfolio
  84. 6.14.5 Genevant Sciences Recent Developments
  85. 6.15 Exelead
  86. 6.15.1 Exelead Company Information
  87. 6.15.2 Exelead Business Overview
  88. 6.15.3 Exelead Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Exelead Lipid Nanoparticle Solutions Product Portfolio
  90. 6.15.5 Exelead Recent Developments
  91. 6.16 Nippon Fine Chemical
  92. 6.16.1 Nippon Fine Chemical Company Information
  93. 6.16.2 Nippon Fine Chemical Business Overview
  94. 6.16.3 Nippon Fine Chemical Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Nippon Fine Chemical Lipid Nanoparticle Solutions Product Portfolio
  96. 6.16.5 Nippon Fine Chemical Recent Developments
  97. 6.17 Lipoid
  98. 6.17.1 Lipoid Company Information
  99. 6.17.2 Lipoid Business Overview
  100. 6.17.3 Lipoid Lipid Nanoparticle Solutions Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Lipoid Lipid Nanoparticle Solutions Product Portfolio
  102. 6.17.5 Lipoid Recent Developments
7 North America
  1. 7.1 North America Lipid Nanoparticle Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Lipid Nanoparticle Solutions Market Size by Country (2021-2026)
  3. 7.3 North America Lipid Nanoparticle Solutions Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Lipid Nanoparticle Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Lipid Nanoparticle Solutions Market Size by Country (2021-2026)
  3. 8.3 Europe Lipid Nanoparticle Solutions Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Lipid Nanoparticle Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Lipid Nanoparticle Solutions Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Lipid Nanoparticle Solutions Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Lipid Nanoparticle Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Lipid Nanoparticle Solutions Market Size by Country (2021-2026)
  3. 10.3 South America Lipid Nanoparticle Solutions Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Lipid Nanoparticle Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Lipid Nanoparticle Solutions Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Lipid Nanoparticle Solutions Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst